CENTROM GROUP : Offer Document Posted

16 March 2009

This announcement is not for release, publication or distribution in
or into any jurisdiction if to do so would constitute a violation of
the relevant laws of such jurisdiction.

RECOMMENDED CASH OFFER FOR CENTROM GROUP PLC

BY

MAYMASK (15) LIMITED

Posting of the Offer Document

On 13 March 2009, the boards of Maymask and Centrom announced that
they had reached agreement on the terms of a recommended cash offer
to be made by Maymask for the entire issued and to be issued share
capital of Centrom.

Maymask is today posting to Centrom Shareholders (and, for
information only, to Centrom Optionholders) a document (the "Offer
Document"), containing the full terms and conditions of the Offer,
together with the relevant Form of Acceptance.

The Offer is open for acceptances until 1.00 pm (London time) on 6
April 2009, unless extended by Maymask.

Those Centrom Shareholders who hold their Centrom Shares in
certificated form (that is, not in CREST), are requested to complete,
sign, witness (if appropriate) and return the Form of Acceptance as
soon as possible (together with their valid share certificate(s)
and/or other document(s) of title) and in any event so as to be
received by Capita Registrars, Corporate Actions, The Registry, 34
Beckenham Road, Beckenham, Kent BR3 4TU no later than 1.00 p.m. on 6
April 2009. A pre-paid reply envelope will be enclosed with the Offer
Document for the Centrom Shareholders' convenience for use in the UK
only.

Those Centrom Shareholders who hold their Centrom Shares in
uncertificated form (that is, in CREST), should NOT return the Form
of Acceptance but instead ensure that an Electronic Acceptance is
made by them or on their behalf and that settlement is no later than
1.00 p.m. on 6 April 2009.

Unless otherwise defined in this announcement, capitalised words and
phrases used in this announcement shall have the same meanings given
to them in the Offer Document.

Copies of the Offer Document and  the Form of Acceptance (for use  by
holders  of  Centrom  Shares  in  certificated  form  only)  will  be
available for inspection following  posting of such documents  during
usual business hours on  Business Days while  the Offer remains  open
for acceptance at the offices of  Watson Burton LLP located at  Floor
29, 30 St Mary Axe, London, EC3A 8BF, by ringing [phone]
and asking to speak to Vera Lyons.




Enquiries:

Maymask
Hugh Blair, Managing Director                  [phone]

Ryecroft Glenton, Financial adviser to Maymask
Nigel Wyrley-Birch                             [phone]

Centrom
Gerald Malone, Chairman                        [phone]

Marshall, Financial adviser to Centrom
John Webb/Robert Luetchford                    [phone]

FinnCap, Nominated adviser to Centrom
Geoff Nash/Rose Herbert                        [phone]


This announcement does not constitute, or form part of, any offer
for, or any solicitation of any offer for, securities of Centrom. Any
acceptance or other response to the Offer should be made only on the
basis of information referred to in the Offer Document and (in
respect of certificated shares) the Form of Acceptance, which Maymask
intends to despatch in due course to Centrom Shareholders and, for
information only, to Centrom Optionholders.

Unless otherwise determined by Maymask and permitted by applicable
law and regulation, the Offer will not be made, directly or
indirectly, in, into or from, or by use of the mails of, or by any
means or instrumentality (including, without limitation, facsimile
transmission, telex, telephone or email) of interstate or foreign
commerce of, or by any facility of a national securities exchange of,
nor will it be made in, into or from any jurisdiction if to do so
would constitute a violation of the relevant laws of such
jurisdiction and the Offer will not be capable of acceptance by any
such use, means, instrumentality or facilities. Accordingly, copies
of any documents relating to the Offer must not be, directly or
indirectly, mailed, transmitted or otherwise forwarded, distributed
or sent, in whole or in part, in, into or from any jurisdiction if to
do so would constitute a violation of the relevant laws of such
jurisdiction and persons receiving such documents (including
custodians, nominees and trustees) must not directly or indirectly
mail, transmit or otherwise forward, distribute or send them in, into
or from any such jurisdiction as to do so may invalidate any
purported acceptance of the Offer.

The availability of the Offer to persons who are not resident in
the United Kingdom may be affected by the laws of the jurisdiction in
which they are resident. Persons who are not resident in the United
Kingdom should inform themselves about, and observe, applicable
requirements.

Ryecroft Glenton  is regulated  for a  range of  investment  business
activities by the Institute of  Chartered Accountants in England  and
Wales and is acting  exclusively for Maymask and  for no one else  in
connection with the Offer and will  not be responsible to any  person
other than Maymask for providing the protections afforded to  clients
of Ryecroft Glenton,  nor for   providing advice in  relation to  the
Offer, the contents of this announcement or any other matter referred
to herein.

Marshall, which is authorised and regulated in the United Kingdom  by
the Financial Services Authority,  is acting exclusively for  Centrom
and for no  one else in  connection with  the Offer and  will not  be
responsible to  any  person  other than  Centrom  for  providing  the
protections afforded to clients of Marshall, nor for providing advice
in relation to the  Offer, the contents of  this announcement or  any
matters referred to herein.


Forward looking statements

This announcement contains statements about Maymask and Centrom  (and
their respective groups and/or  subsidiary undertakings) that are  or
may  be  forward-looking  statements.   All  statements  other   than
statements of historical facts included  in this announcement may  be
forward-looking  statements.   Without  limitation,  any   statements
preceded or followed by or that include the words "targets", "plans",
"believes",   "expects",    "aims",   "intends",    "will",    "may",
"anticipates", "estimates", "projects" or  words or terms of  similar
substance or the  negative thereof  are forward-looking  statements.
Forward-looking statements  include (without  limitation)  statements
relating to the following:

(i)          future   capital   expenditures,   expenses,   revenues,
earnings, synergies,  economic performance,  indebtedness,  financial
condition, dividend policy, losses and future prospects;

(ii)        business and management strategies and the expansion  and
growth of  Maymask  or  Centrom operations  and  potential  synergies
resulting from the Offer; and

(iii)       the effects  of government regulation  on the Maymask  or
Centrom businesses.

These  forward-looking  statements  are  not  guarantees  of   future
performance.  They have not been reviewed by the auditors of  Maymask
or of Centrom.  They involve  known and unknown risks,  uncertainties
and other factors which may cause the actual results, performance  or
achievements  of  any  such  person,  or  industry  results,  to   be
materially different from  any results,  performance or  achievements
expressed or  implied  by  such  forward-looking  statements.   These
forward-looking  statements   are  based   on  numerous   assumptions
regarding the present and future business strategies of such  persons
and the environment in  which each will operate  in the future.   You
are cautioned  not to  place undue  reliance on  any  forward-looking
statements, which speak  only as  of the  date they  were made.   All
subsequent oral or written forward-looking statements attributable to
Maymask or Centrom or any members  of their respective groups or  any
persons acting  on  their behalf  are  expressly qualified  in  their
entirety by  the  cautionary statement  above.   All  forward-looking
statements included  in this  announcement are  based on  information
available on  the  date hereof.   Investors  should not  place  undue
reliance on such forward-looking  statements and neither Maymask  nor
Centrom undertake any  obligation to  publicly update  or revise  any
forward-looking statements.

Dealing Disclosure Requirements

Under the provisions of Rule  8.3 of the Code,  if any person is,  or
becomes "interested" (directly or  indirectly) in 1%  or more of  any
class of  "relevant securities"  of Centrom,  all "dealings"  in  any
"relevant securities"  of  that company  (including  by means  of  an
option in  respect  of,  or  a derivative  referenced  to,  any  such
"relevant securities") must  be publicly disclosed  by no later  than
3.30 p.m. on  the Business  Day following  the date  of the  relevant
transaction.  This requirement will continue until the date on  which
the Offer becomes, or is  declared, unconditional as to  acceptances,
lapses or  is otherwise  withdrawn  or on  which the  "offer  period"
otherwise ends.  If two or more  persons act together pursuant to  an
agreement or understanding, whether formal or informal, to acquire an
"interest" in "relevant securities" of  Centrom, they will be  deemed
to be a single person for the purpose of Rule 8.3.

Under the  provisions of  Rule 8.1  of the  Code, all  "dealings"  in
"relevant securities" of Centrom by Maymask or Centrom, or by any  of
their respective "associates",  must be  disclosed by  no later  than
12.00 noon on  the Business Day  following the date  of the  relevant
transaction.

A  disclosure  table,  giving  details  of  the  companies  in  whose
"relevant securities" "dealings" should be disclosed, and the  number
of such securities in issue, can  be found on the Panel's website  at
www.thetakeoverpanel.org.uk.

"Interests in securities" arise, in  summary, when a person has  long
economic exposure, whether conditional or absolute, to changes in the
price of  securities.  In  particular, a  person will  be treated  as
having an  "interest"  by  virtue  of the  ownership  or  control  of
securities, or by virtue of any  option in respect of, or  derivative
referenced to, securities.

Terms in quotation marks are defined  in the Code, which can also  be
found on the Panel's website. If you  are in any doubt as to  whether
or not you  are required to  disclose a "dealing"  under Rule 8,  you
should consult the Panel.

---END OF MESSAGE---


This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement.



Copyright © Hugin AS 2009. All rights reserved.